RxDoctor Payments Data

Brian Damitz

Podiatrist · Chesterton, INNPI 1033420534

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (42.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Arthrex at 45.9% of the total. Reporting peaked in 2019 at $5,233 and has fallen 70.9% since, to $1,525 in 2025. Among podiatrist clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,046in general payments, 2019–2025

Across 98 payments — averaging $112.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$5K
  • Stryker$5K
  • Johnson & Johnson$208
  • Treace Medical Concepts, Inc.$175
  • Medwest Associates$133
  • Encore Medical, LP$75
  • plus $415 from 12 others

What the payments were for

  • Travel & lodging$3,75034%
  • Food & beverage$2,62624%
  • Education$4,67042%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,046 in reported general payments places this provider in the 90th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$138,660
Medicare patients
433
Services billed
2,763

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin70$479
Clotrimazole20$417
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen60$387
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen35$299
Cephalexin29$187
Methylprednisolone25$113
Meloxicam36$103
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$76

Paid to pharmacies, not to this prescriber.

Other podiatrist in Chesterton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →